| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Kaposi's sarcoma complete clinical response after sorafenib administration
|
Ardavanis, A.
|
|
|
19 |
9 |
p. 1658-1659
|
artikel
|
| 2 |
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
|
Pivot, X.
|
|
|
19 |
9 |
p. 1547-1552
|
artikel
|
| 3 |
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
|
Rayson, D.
|
|
|
19 |
9 |
p. 1530-1539
|
artikel
|
| 4 |
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases
|
Shivakumar, R.
|
|
|
19 |
9 |
p. 1634-1638
|
artikel
|
| 5 |
Carcinomas of an unknown primary site: a curable disease?
|
Levy, A.
|
|
|
19 |
9 |
p. 1657-1658
|
artikel
|
| 6 |
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
|
Telli, M.L.
|
|
|
19 |
9 |
p. 1613-1618
|
artikel
|
| 7 |
Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer
|
Hines, S.L.
|
|
|
19 |
9 |
p. 1561-1565
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
19 |
9 |
p. ii-iii
|
artikel
|
| 9 |
Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice
|
Zhong, Q.
|
|
|
19 |
9 |
p. 1584-1591
|
artikel
|
| 10 |
[18F]-FDG–PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
|
de Wit, M.
|
|
|
19 |
9 |
p. 1619-1623
|
artikel
|
| 11 |
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
|
Knab, B.R.
|
|
|
19 |
9 |
p. 1650-1654
|
artikel
|
| 12 |
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity
|
Horacek, J.M.
|
|
|
19 |
9 |
p. 1656-1657
|
artikel
|
| 13 |
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
|
Gravalos, C.
|
|
|
19 |
9 |
p. 1523-1529
|
artikel
|
| 14 |
in this issue
|
|
|
|
19 |
9 |
p. 1517
|
artikel
|
| 15 |
Low influenza vaccination rate among patients receiving chemotherapy for cancer
|
Loulergue, P.
|
|
|
19 |
9 |
p. 1658
|
artikel
|
| 16 |
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
|
McGowan, P.M.
|
|
|
19 |
9 |
p. 1566-1572
|
artikel
|
| 17 |
Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy
|
Heron, D.E.
|
|
|
19 |
9 |
p. 1639-1643
|
artikel
|
| 18 |
Need for global action for cancer control
|
Boyle, P.
|
|
|
19 |
9 |
p. 1519-1521
|
artikel
|
| 19 |
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
|
Chauffert, B.
|
|
|
19 |
9 |
p. 1592-1599
|
artikel
|
| 20 |
Preoperative [18F] FDG–PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology
|
Emmering, J.
|
|
|
19 |
9 |
p. 1573-1577
|
artikel
|
| 21 |
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab
|
Bishton, M.J.
|
|
|
19 |
9 |
p. 1629-1633
|
artikel
|
| 22 |
Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer
|
Gravis, G.
|
|
|
19 |
9 |
p. 1624-1628
|
artikel
|
| 23 |
Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery
|
Cacheux, W.
|
|
|
19 |
9 |
p. 1659-1661
|
artikel
|
| 24 |
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
|
Zucali, P.A.
|
|
|
19 |
9 |
p. 1605-1612
|
artikel
|
| 25 |
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
|
Wang, J.
|
|
|
19 |
9 |
p. 1578-1583
|
artikel
|
| 26 |
Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004
|
Meulenbeld, H.J.
|
|
|
19 |
9 |
p. 1600-1604
|
artikel
|
| 27 |
Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report
|
Mego, M.
|
|
|
19 |
9 |
p. 1655-1656
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
19 |
9 |
p. iv-v
|
artikel
|
| 29 |
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series
|
Veronesi, U.
|
|
|
19 |
9 |
p. 1553-1560
|
artikel
|
| 30 |
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
|
Puglisi, F.
|
|
|
19 |
9 |
p. 1541-1546
|
artikel
|
| 31 |
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
|
Schmidt, E.
|
|
|
19 |
9 |
p. 1644-1649
|
artikel
|
Tijdschrift beschrijving